The "United States Proton Therapy Market Report Forecast by Indication. States and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering.
United States Proton Therapy market had reached US$1.04 billion in 2024 and is estimated to reach US$2.67 billion during the forecast period from 2025 to 2033 at a compound annual growth rate of 10.97%
Increasing incidence of cancer, technology advancement in proton therapy, and need for non-invasive precise treatments in patients suffering from cancer stimulate growth in the proton therapy market. With growing awareness of the benefits in the United States, the market is assumed to expand greatly as it will establish it a global leader in advanced care for cancer.
Proton therapy is a highly advanced form of radiation that utilizes protons instead of X-rays for cancer treatment. Narrower radiation margins because of precise treatment which will harm cancer cells less than other tissues surrounding will make it especially suitable for use near vital organs such as the brain, spine, or heart. Among the advantages of proton therapy: Reduction of side effects and high outcome percents have helped many to take advantage of it in a bid to treat various forms of cancers like pediatric cancers, prostate cancer, and head and neck cancers.
Proton therapy is fast being adopted in the United States, where its efficiency and growing awareness among patients and healthcare providers are contributing factors. Proton therapy consumes the greatest number of therapies in the United States, which boasts of a highly developed health care infrastructure and several proton therapy centers. With cancer incidence projected to rise worldwide, growing technological advancements in proton therapy spur demand in the treatment. Proton therapy insurance is also becoming more accessible, thereby opening more access to more patients in the country.
Increasing Cancer Incidence in USA
The increasing incidence of cancer is the most significant growth driver for the proton therapy market. Every year, millions of new cancer cases are diagnosed in the United States, and most of them require advanced treatment. Proton therapy is much more precise radiation treatment without the destruction of surrounding healthy tissues. It would be very ideal for children and cancers located at close proximity to critical organs.
With the continued increase in cancer incidence, an increasing need for effective and less-invasive treatments like proton therapy stimulates the development of proton therapy centers around the country. According to Pubmed, new cases of cancer that are bound to be registered in the United States amount to 2,001,140 and 611,720 cancer deaths in 2024.
Technological Advancements in Proton Therapy
New technology advancements have witnessed a great share in the growth of the proton therapy market in the United States. Most of its recent developments including pencil beam scanning and image-guided proton therapy have improved the precision and velocity of treatments. This is, therefore, making proton therapy much more appealing. Other benefits are smaller size designs for proton therapy systems that decrease both the cost and space requirements, thus making it possible for more treatment facilities to offer this type of treatment.
Advances enhance patient outcome with a lower total cost of care. In addition, as newer technology becomes available, access to proton therapy, as well as its effectiveness when applied to cancer treatment, increases. January 2024, The National Association for Proton Therapy (NAPT) released a new study in the International Journal of Radiation Oncology-Biology-Physics, which summarizes the application of proton therapy in treating various diseases and tumor locations.
Expanding Insurance Coverage
Another reason why the proton therapy industry is doing so well is due to the expansion of insurance coverage in the United States. Generally, one of the significant contributory factors to the generally restricted access to the therapy has been its expensive treatment costs. However, increasing knowledge of its benefits, increasingly more insurance is underwriting it for various kinds of cancers, especially when other traditional forms of radiation therapy risk causing more side effects.
Such broad coverage makes the therapy available to an all-inclusive range of patients, thus the demand increases. Improvement of reimbursement policies will encourage the proton therapy market in the coming future. The UC Board of Regents has also cleared for construction a next-generation UCSF cancer treatment center, UCSF research space, a life sciences incubator, and primary and specialty care clinics as part of the redevelopment of the Dogpatch Power Station in southeast San Francisco.
California Proton Therapy Industry
The proton therapy industry in California is booming due to its well-developed healthcare infrastructure and growing numbers of cancer patients in the state. It's on the front edge of innovation in cancer treatment and contains some of the world's most impressive proton therapy centers, including Los Angeles and San Diego, California.
The focus of the state on personalized medicine and its non-invasive approach drives high demand for proton therapy. Growing public awareness of the advantages of proton therapy and support at the state level for advanced medical technology are further advancing the industry. California is likely to be the leader in the global market of proton therapy for a long time.
United States Proton Therapy Company Analysis
Some major companies in the United States proton therapy industry are IBA, Varian Medical System, Hitachi Ltd, Mevion Medical Systems, and Mitsubishi Electric Corporation.
United States Proton Therapy Company News
June 2024, Atlantic Health System plans to acquire and install a MEVION Proton Therapy SystemT at the Carol G. Simon Cancer Center in New Jersey, scheduled for installation in 2025.
March 2023, The first participant in a clinical trial of FLASH proton therapy for chest bone cancers has completed treatment at the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 100 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value (USD) in 2024 | $1.04 Billion |
| Forecasted Market Value (USD) by 2033 | $2.67 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | United States |
Key Topics Covered:
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenge
5. United States Proton Therapy Market
5.1 Historical Trend
5.2 Forecast Trend
6. Market Share Analysis
6.1 By Indication
6.2 By Set-up Type
6.3 By State
7. Indication
7.1 Head & Neck Cancer
7.2 Sarcoma
7.3 Pediatric Cancer
7.4 Gastro-intestinal Cancer
7.5 Prostate Cancer
7.6 Lung Cancer
8. Set-up Type
8.1 Single Room
8.2 Multi - Room
9. State
9.1 California (CA)
9.2 Massachusetts (MA)
9.3 Texas (TX)
9.4 Florida (FL)
9.5 Oklahoma (OK)
9.6 Pennsylvania (PA)
9.7 Illinois (IL)
9.8 Virginia (VA)
9.9 New Jersey (NJ)
9.10 Washington (WA)
9.11 Missouri (MO)
9.12 Tennessee (TN)
9.13 Louisiana (LA)
9.14 Minnesota (MN)
9.15 Arizona (AZ)
9.16 Maryland (MD)
9.17 Ohio (OH)
9.18 Michigan (MI)
9.19 District of Columbia (DC)
9.20 Georgia (GA)
9.21 New York (NY)
9.22 Alabama (AL)
9.23 Utah (UT)
9.24 Arkansas (AR)
10. Porter's Five Forces Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat
12. Reimbursement Policy
12.1 Reimbursement Policies for Patients
12.2 Reimbursement for Institutions, Stakeholders and Manufacturers
13. Components of a Standard Proton Therapy Center
13.1 Proton Accelerator
13.1.1 Synchrotrons (example: LLUMC at Loma Linda)
13.1.2 Cyclotrons (example: MGH Boston)
13.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
13.1.4 Linacs (Rome)
13.1.5 H-minus Synchrotrons
13.1.6 Separated Sector Cyclotrons
13.1.7 Super-conducting Cyclotrons
13.1.8 Fast Cycling Synchrotron
13.2 Beam Transport System
13.3 Beam Delivery System
13.3.1 The Passive Scattering Technique
13.3.2 Beam Scanning
13.4 Nozzle
13.4.1 Single Scattering
13.4.2 Double Scattering
13.4.3 Uniform Scanning Nozzle
13.4.4 Pencil Scanning Nozzle
13.5 Treatment Planning System
13.6 Image Viewers
13.7 Patient Positioning System (PPS)
13.8 Human Resource
14. Key Players Analysis
14.1 IBA
14.1.1 Business overview
14.1.2 Key Persons
14.1.3 Recent Development & Strategies
14.1.4 Sales Analysis
14.2 Varian Medical System
14.3 Hitachi Ltd.
14.4 Mevion Medical Systems
14.5 Mitsubishi Electric Corporation
For more information about this report visit https://www.researchandmarkets.com/r/usk1bn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241203277860/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
